Search results
Results from the WOW.Com Content Network
A National Provider Identifier (NPI) is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). The NPI has replaced the Unique Physician Identification Number (UPIN) as the required identifier for Medicare services, and is used by other payers ...
Stepping ID is a product revision number assigned due to fixed errata or other changes. The actual processor model is derived from the Model, Extended Model ID and Family ID fields. If the Family ID field is either 6 or 15, the model is equal to the sum of the Extended Model ID field shifted left by 4 bits and the Model field.
AMD now refers to the codename K8 processors as the Family 0Fh processors. 10h and 0Fh refer to the main result of the CPUID x86 processor instruction. In hexadecimal numbering, 0F(h) (where the h represents hexadecimal numbering) equals the decimal number 15, and 10(h) equals the decimal number 16.
move to sidebar hide. From Wikipedia, the free encyclopedia
A unique physician identification number (UPIN) was a six-character alpha-numeric identifier used by Medicare to identify doctors in the United States. They were discontinued in June 2007 [ 1 ] and replaced by National Provider Identifier , or NPI numbers.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Takes as input a CPUID leaf index in EAX and, depending on leaf, a sub-index in ECX. Result is returned in EAX,EBX,ECX,EDX. [e] Instruction is serializing, and causes a mandatory #VMEXIT under virtualization. Support for CPUID can be checked by toggling bit 21 of EFLAGS (EFLAGS.ID) – if this bit can be toggled, CPUID is present. Usually 3 [f]
The Unique Device Identification (UDI) System is intended to assign a unique identifier to medical devices within the United States, Europe, China, South Korea, Saudi Arabia and Taiwan. [1] It was signed into law in the US on September 27, 2007, as part of the Food and Drug Administration Amendments Act (Section 226) of 2007 .